Reuters: Roche files Tarceva for first-line lung cancer use

[NaDiNe]

Roche files Tarceva for first-line lung cancer use
      
   
      

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Thursday it had submitted its Tarceva drug to the European Medicines Agency for use as a first-line treatment for patients with advanced non-small-cell lung cancer.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login